SM 11044

Drug Profile

SM 11044

Alternative Names: SM-11044

Latest Information Update: 19 Jan 1996

Price : $50

At a glance

  • Originator Sumitomo Pharmaceuticals
  • Class Antiasthmatics; Bronchodilators; Muscle relaxants
  • Mechanism of Action Beta-adrenergic receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Asthma

Most Recent Events

  • 19 Jan 1996 Discontinued-Preclinical for Asthma in Japan (Unknown route)
  • 10 Aug 1995 No-Development-Reported for Asthma in Japan (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top